Timolol Maleate NDC 82260-496

NDC codes

FDA NDC Directory

Product NDC (as listed)82260-496Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82260-0496Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82260-496-05	82260049605	6 POUCH in 1 CARTON (82260-496-05) / 10 CONTAINER in 1 POUCH / .3 mL in 1 CONTAINERMarketed from Feb 17, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Timolol Maleate
Generic name (nonproprietary): timolol maleate
Active ingredients: Timolol maleate — 6.8 mg/mL
Dosage form: Solution
Route: Ophthalmic
Labeler: Bausch & Lomb Americas Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 019463
Marketing start: Feb 17, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 82260-496_2f9f1dcc-6988-edb0-e063-6394a90ac484SPL ID 2f9f1dcc-6988-edb0-e063-6394a90ac484SPL set ID 036dc753-1698-4c69-9bcf-752c7061203cRxCUI 1922894UNII P8Y54F701R
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482260049605 followed by a unit qualifier and the quantity

Package 82260-0496-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 5, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Preservative-free Timolol Maleate Ophthalmic Solution in OCUDOSE is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Preservative-free Timolol Maleate Ophthalmic Solution in OCUDOSE may be used when a patient is sensitive to the preservative in Timolol Maleate Ophthalmic Solution, benzalkonium chloride, or when use of a preservative-free topical medication is advisable.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 019463

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019463
Product	Strength	Form · route	Labeler	Product NDC
Timoptic in Ocudosetimolol maleate	Timolol maleate 3.4 mg/mL	SolutionOphthalmic	Bausch & Lomb Incorporated	24208-498
Timoptic in Ocudosetimolol maleate	Timolol maleate 6.8 mg/mL	SolutionOphthalmic	Bausch & Lomb Incorporated	24208-499